SCHOTT PHARMA INH O.N./ DE000A3ENQ51 /
26/07/2024 12:01:04 | Chg. +0.240 | Volume | Bid12:01:04 | Ask12:01:04 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
32.240EUR | +0.75% | 2,584 Turnover: 82,999.660 |
32.240Bid Size: 69 | 32.280Ask Size: 63 | 4.86 bill.EUR | 0.46% | 31.96 |
Assets
|
2023 IFRS in mill. EUR |
||
---|---|---|---|
Property and Equipment | 637.8000 | ||
Intangible Assets | 30.9400 | ||
Long-Term Investments | 79.0500 | ||
Fixed Assets | 763.4900 | ||
Inventories | 138.9400 | ||
Accounts Receivable | 156.6500 | ||
Cash and Cash Equivalents | 24.3500 | ||
Current Assets | 468.3300 | ||
Total Assets | 1,231.8200 |
Liabilities
|
2023 IFRS in mill. EUR |
||
---|---|---|---|
Accounts Payable | 60.5200 | ||
Long-term debt | - | ||
Liabilities to Banks | - | ||
Provisions | 58.4000 | ||
Liabilities | 539.6400 | ||
Share Capital | - | ||
Total Equity | 690.4300 | ||
Minority Interests | 1.7400 | ||
Total liabilities equity | 1,231.8200 |
Income Statement
|
2023 IFRS in mill. EUR |
||
---|---|---|---|
Revenues | 898.6000 | ||
Depreciation (total) | - | ||
Operating Result | 192.3800 | ||
Interest Income | -2.0300 | ||
Income Before Taxes | - | ||
Income Taxes | 33.8600 | ||
Minority Interests Profit | .0920 | ||
Net Income | 151.8400 |
Per Share
Cash Flow
|
2023 IFRS in mill. EUR |
||
---|---|---|---|
Cash Flow from Operating Activities | 181.6500 | ||
Cash Flow from Investing Activities | -171.4100 | ||
Cash Flow from Financing | -11.3900 | ||
Decrease / Increase in Cash | - | ||
Employees | 4,646 |